Goldline
This article was originally published in The Tan Sheet
Executive Summary
April 8 warning letter from FDA charges that labeling for Goldline Bacitracin Ointment makes unsubstantiated claims such as "aids in the healing of minor burns, cuts [and] scrapes." The letter also cites the firm for not bearing an appropriate statement of identity on the principal display panel for Goldline Vitamin E Cream. Goldline said it informed FDA on April 20 that it told the products' manufacturer, Clay Park of Bronx, New York, of the deficiencies and that Clay Park will work to bring the items into compliance.